INFLUENZA
- Prevention of influenza virus should be considered well in advance of the development of neutropenia.
- Annual immunization with an inactivated influenza vaccine is recommended for all patients being treated for cancer
- generally administered >2 weeks before chemotherapy starts or, between chemotherapy cycles and at least seven days after the last cycle
HSV & VZV
- Reactivation of herpes simplex virus (HSV)-1 and HSV-2 are important causes of morbidity in patients with acute leukemia and those undergoing HCT
- varicella-zoster virus (VZV) reactivation occurs commonly in HCT recipients who are not receiving prophylaxis
- Patients who are seropositive for HSV and who are undergoing allogeneic HCT or induction chemotherapy for acute leukemia should receive antiviral prophylaxis withacyclovir (400 mg orally 3/4 times daily or 800 mg orally twice daily)
- continued until recovery of the white blood cell count or resolution of mucositis
- In HCT recipients who are seropositive for VZV, antiviral prophylaxis with acyclovir (800 mg orally twice daily) is typically continued for one year or longer in those with chronic GVHD and/or who require ongoing immunosuppression
CMV
- Reactivation of cytomegalovirus (CMV) does not occur commonly in patients, preemptive therapy is therefore not indicated
- In contrast, HCT recipients are at significant risk for CMV reactivation
HEPATITIS B
- Patients receiving chemotherapy who have a history of previous hepatitis B virus infection are at risk of reactivation with a flare of hepatitis that may potentially result in hepatic failure
- Antiviral prophylaxis should be considered for such patients at risk for reactivation and should be continued for at least six months after the completion of chemotherapy
- This strategy can reduce the risk of reactivation from 24 to 53 percent to 0 to 5 percent
REFERENCE:
- www.uptodate.com
- NCCN Guidelines version 01.2013 Prevention and Treatment of Cancer Related Infection
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.